James A. Robb, Margaret L. Gulley, Patrick L. Fitzgibbons, Mary F. Kennedy, L. Mark Cosentino, Kay Washington, Rajesh C. Dash, Philip A. Branton, Scott D. Jewell, and Rosanna L. Lapham (2013) A Call to Standardize Preanalytic Data Elements for Biospecimens. Archives of Pathology & Laboratory Medicine In-Press.
Early Online Release
A Call to Standardize Preanalytic Data Elements for Biospecimens
James A. Robb , MD; Margaret L. Gulley , MD; Patrick L. Fitzgibbons , MD; Mary F. Kennedy , CT(ASCP), MPH; L. Mark Cosentino ,DPM; Kay Washington , MD; Rajesh C. Dash , MD; Philip A. Branton , MD; Scott D. Jewell , PhD; Rosanna L. Lapham , MD
"Successful implementation of genomically informed, precision, personalized health care requires the availability of high-quality biospecimens. These biospecimens are fundamentally necessary for the production of accurate downstream test results in clinical or research settings. These results, in turn, form the basis for determining optimal patient management and research outcomes. A critical ingredient in creating high-quality and high-value biospecimens is the clinical and processing information attached (annotated) and accrued to each biospecimen. Currently, only limited and/or relatively general recommendations are available as to what preanalytic information should be collected and attached to each biospecimen for clinical care and/or research.2–16 As a result, there is great variability in the collected clinical information, as well as in the quality of that information. A dynamic list of evidence-based and/or expert opinion–defined, preanalytic, clinical data fields should be useful for both patient care and research biospecimen annotation."
No comments:
Post a Comment